8-K: National Health Investors Reports Strong Q4 2023 Results, Exceeds Guidance

National Health Investors (NHI) announced strong fourth-quarter and full-year 2023 results, exceeding initial guidance and demonstrating significant improvements in key financial metrics.

Summary

• National Health Investors (NHI) reported a net income of $0.74 per diluted share for the fourth quarter of 2023, a significant increase from $0.04 in the same period of the previous year.
• For the full year 2023, net income per diluted share was $3.13, compared to $1.48 in 2022.
• NAREIT FFO per diluted share for Q4 2023 was $1.09, up from $0.74 in Q4 2022, and for the full year, it was $4.39, compared to $3.55 in the prior year.
• Normalized FFO per diluted share was $1.09 for the quarter and $4.33 for the year, compared to $0.85 and $4.30 respectively in the prior year.
• Normalized FAD was $47.3 million for the quarter and $187.8 million for the year, compared to $44.7 million and $201.0 million respectively in the prior year.
• The results include approximately $2.0 million and $5.7 million in the repayment of previously deferred rent and related interest for the quarter and full year respectively.
• NHI is issuing 2024 annual guidance with NAREIT FFO and Normalized FFO per diluted share in the range of $4.31 $4.37 and Normalized FAD in the range of $191.3 million $194.1 million.
• Rental income increased by $7.0 million, primarily due to pandemic-related rent repayments and new investments.
• The company sold three properties in Q4 2023 for net proceeds of approximately $7.0 million and 12 properties for the full year for net proceeds of approximately $59.1 million.
• As of December 31, 2023, NHI had $1.1 billion in net debt, with $245.0 million outstanding on its revolving credit facility.
• A new stock repurchase plan for up to $160 million was approved by the board of directors.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong financial results, exceeding guidance, and positive trends in the senior housing industry. The company's management also expresses confidence in the future outlook.

Positives

• The company exceeded expectations for the fourth quarter, driven by deferral repayments and no unexpected rent concessions.
• Full-year NAREIT FFO, NFFO, and FAD all exceeded the midpoint of the initial 2023 guidance.
• The senior housing industry is showing signs of recovery, with persistent improvement in EBITDARM coverage.
• SHOP results benefited from a sequential occupancy gain of 420 basis points and a 350-basis point improvement in the margin.
• The company maintains a strong financial profile with leverage at 4.4 times net debt-to-adjusted EBITDA.
• The 2024 guidance implies a return to growth with better visibility due to portfolio optimization.
• The company is in compliance with all debt covenants and has investment grade credit ratings.
• The company has $500 million available under the at-the-market program.

Negatives

• Normalized FAD for the full year 2023 was $187.8 million, down from $201.0 million in 2022.
• Interest expense increased by approximately $2.4 million due to increased interest rates and borrowings.
• The company did not make any repurchases under the 2023 stock repurchase plan.
• The company has $273 million outstanding under the revolving credit facility as of January 31, 2024.

Risks

• The company's performance is dependent on the operating success of its tenants and borrowers.
• Tenants and borrowers may become subject to bankruptcy or insolvency proceedings.
• A significant percentage of the portfolio is concentrated with a small number of tenants.
• Pandemics, epidemics, or outbreaks could negatively impact the operators' business.
• Governmental regulations and payors, particularly Medicare and Medicaid, could affect reimbursement rates.
• Increased liability claims and insurance costs could adversely affect tenants and borrowers.
• The illiquidity of real estate investments could impede the company's ability to respond to adverse changes.
• Investments in unconsolidated entities carry risks, including a lack of sole decision-making authority.
• Inflation and increased interest rates could negatively impact the company.
• The company is dependent on revenues derived mainly from fixed-rate investments while a portion of debt bears interest at variable rates.

Future Outlook

NHI's 2024 guidance includes NAREIT FFO and Normalized FFO per diluted share in the range of $4.31 $4.37 and Normalized FAD in the range of $191.3 million $194.1 million. The company anticipates continued rent collections, asset dispositions, loan repayments, and SHOP NOI growth in a range of 25%-30%.

Management Comments

• Eric Mendelsohn, NHI President and CEO, stated, 'We finished 2023 on a positive note as the fourth quarter results exceeded our expectations driven by over $2.0 million in deferral repayments, no unexpected rent concessions and 24.4% sequential SHOP NOI growth compared to the third quarter of 2023.'
• Mr. Mendelsohn continued, 'For the full year, our NAREIT FFO, NFFO and FAD all exceeded the midpoint of our initial February 2023 guidance.'
• Mr. Mendelsohn also stated, 'The senior housing industry continues to recover, and we are experiencing persistent improvement in our EBITDARM coverage, particularly with our need-driven operators which have produced seven straight quarters of increased coverage.'
• Mr. Mendelsohn concluded, 'We continue to maintain our best-in-class financial profile with leverage at just 4.4 times net debt-to-adjusted EBITDA. We believe this creates a significant strategic advantage as the supply of capital is shrinking while demand is increasing.'

Industry Context

The announcement reflects a positive trend in the senior housing industry, with NHI demonstrating strong performance and recovery. The company's focus on need-driven operators and portfolio optimization aligns with the broader industry's efforts to improve occupancy and financial stability.

Comparison to Industry Standards

• NHI's reported NAREIT FFO per diluted share of $4.39 for the full year 2023 is a strong result compared to other healthcare REITs. For example, Welltower (WELL) reported a full year 2023 normalized FFO per share of $3.52, and Ventas (VTR) reported a normalized FFO per share of $3.08 for the same period. This indicates that NHI is performing well in comparison to its peers.
• The company's net debt to adjusted EBITDA of 4.4x is within its target range of 4.0x 5.0x, which is a conservative leverage level compared to some other REITs that may operate with higher leverage ratios. For example, some REITs may operate with leverage ratios closer to 6.0x or higher.
• The sequential SHOP NOI growth of 24.4% is a significant improvement and suggests that NHI's senior housing operating portfolio is performing well compared to industry averages. Many senior housing operators are still recovering from the pandemic, and this level of growth is a positive sign for NHI.
• The company's occupancy rates, particularly in the SHOP segment, show a positive trend, with a 420 basis point sequential gain. This is a key metric for senior housing REITs, and NHI's improvement indicates a strong recovery in occupancy rates compared to industry averages.

Stakeholder Impact

• Shareholders will benefit from the strong financial results and the new stock repurchase plan.
• Employees may experience increased job security due to the company's positive performance.
• Tenants and borrowers may benefit from the company's continued financial stability.
• Customers (residents) may experience improved services due to the company's focus on operational improvements.

Next Steps

• NHI will host a conference call on February 21, 2024, to discuss fourth-quarter results.
• The company will continue to execute its 2024 guidance, including rent collections, asset dispositions, loan repayments, and SHOP NOI growth.
• The company will implement the new $160 million stock repurchase plan.

Key Dates

Keywords

REIT, Senior Housing, Healthcare Real Estate, NAREIT FFO, Normalized FFO, Normalized FAD, Occupancy, Net Operating Income, EBITDARM, Stock Repurchase, Debt, Real Estate Investments